Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
memo - Magazine of European Medical Oncology

Open Access 23-02-2024 | Metastasis | case report

Seminal vesicle metastasis from transverse colon adenocarcinoma: a unique case report

Authors: Juliana Arenas Hoyos, Julian Serrano Giraldo, Andres Felipe Gutierrez Rojas

Published in: memo - Magazine of European Medical Oncology

Login to get access

Summary

Background

Seminal vesicle metastasis from colon adenocarcinoma is very rare, with only two case reports in the literature. Also, positron emission tomography/computed tomography (PET/CT) imaging in the diagnosis of seminal vesicle tumors seems to have a promising role in its detection, but there have been few reports about its use, in part due to the rarity of the disease.

Case presentation

We report the case of a 64-year-old male patient with colon adenocarcinoma who at 6 years after the diagnosis presented with metastasis to the seminal vesicles, which responded remarkably to chemotherapy, but 2 years later had a relapse at the seminal vesicles. Imaging with PET/CT was helpful for the diagnosis of this case.

Conclusion

Our case is unique, as there are no previous reports in the literature on the relapse of metastatic colon adenocarcinoma in the seminal vesicles. Imaging with PET/CT showed compromise of the seminal vesicles in our case; hence, this imaging technique seems to have a promising role in detecting metastatic seminal vesicle tumors.
Literature
1.
Hsu YL, Lin IC, Tung CL. 18F-FDG PET/CT of Seminal Vesicle Metastasis from Ascending Colon Adenocarcinoma. Clin Nucl Med. 2017;42(2):138–9.CrossRefPubMed
2.
Atici SD, Ugurlu L, Aydin C. Isolated metastasis of left seminal vesicle due to colon adenocarcinoma: An unusual pattern of metastasis. J Coll Physicians Surg Pakistan. 2021;31(6):752–3.CrossRef
3.
Kim B, Kawashima A, Ryu JA, Takahashi N, Hartman RP, King BF. Imaging of the seminal vesicle and vas deferens. Radiographics. 2009;29(4):1105–21.CrossRefPubMed
4.
Lopez-Beltran A, Menendez CL, Montironi R, Cheng L. The Prostate and Seminal Vesicles. In: Lopez-Beltran A, Menendez CL, Montironi R, Cheng L, editors Rare Tumors and Tumor-like Conditions in Urological Pathology. Springer International Publishing: cham, 2015. pp 195-310 https://​doi.​org/​10.​1007/​978-3-319-10253-5_​3.
5.
6.
Egevad L, Ehrnström R, Håkansson U, Grabe M. (2007) Primary Seminal Vesicle Carcinoma Detected at Transurethral Resection of Prostate. Urology. 69(4):778.e11–778.e13.
7.
Sala E, Akin O, Moskowitz CS, Eisenberg HF, Kuroiwa K, Ishill NM, et al. Endorectal MR imaging in the evaluation of seminal vesicle invasion: Diagnostic accuracy and multivariate feature analysis. Radiology. 2006;238(3):929–37.CrossRefPubMed
8.
Bhat A, Banerjee I, Kryvenko ON, Satyanarayana R. Primary seminal vesicle adenocarcinoma: A lethal yet cryptic malignancy with review of literature. BMJ Case Rep. 2019;12(12):1–6.CrossRef
9.
Bhardwaj N, Rastogi P, Attri VS, Bora GS, Gorsi U. Primary seminal vesicle adenocarcinoma: A case report of rare entity and discussion of its differential diagnosis using immunohistochemical approach for the core biopsy specimen. Andrologia. 2020;52(3):1–5.CrossRef
10.
Ormsby AH, Haskell R, Jones D, Goldblum JR. Primary seminal vesicle carcinoma: An immunohistochemical analysis of four cases. Mod Pathol. 2000;13(1):46–51.CrossRefPubMed
11.
Kitajima K, Yamamoto S, Fukushima K, Minamimoto R, Kamai T, Jadvar H. Update on advances in molecular PET in urological oncology. Jpn J Radiol. 2016;34(7):470–85.CrossRefPubMedPubMedCentral
12.
Høilund-Carlsen PF, Poulsen MH, Petersen H, Hess S, Lund L. FDG in urologic malignancies. PET Clin. 2014;9(4):457–68.CrossRefPubMed
13.
Lal H, Yadav P, Jena R, Jain M. Metastatic primary seminal vesicle adenocarcinoma: Management of a rare tumour with multiagent chemotherapy and hormonal therapy. BMJ Case Rep. 2017;2017.
14.
Mizuno N, Fujikawa N, Murakami T, Suzuki T, Ikeda I. A case of primary seminal vesicle cancer detected by FDG-PET/CT. Nihon Hinyokika Gakkai Zasshi. 2012;103(6):704–7.PubMed
15.
Jadvar H, Colletti PM, Delgado-Bolton R, Esposito G, Krause BJ, Iagaru AH, et al. Appropriate use criteria for 18F-FDG PET/CT in restaging and treatment response assessment of malignant disease. J Nucl Med. 2017;58(12):2026–37.CrossRefPubMed
16.
Cheng XB, Lu ZQ, Lam W, Yiu MK, Li JS. Solitary seminal vesicle metastasis from ileal adenocarcinoma presenting with hematospermia: A case report. World J Clin Cases. 2021;9(23):6775–80.CrossRefPubMedPubMedCentral
17.
Sollini M, Silvotti M, Casali M, Giovanardi F, Zadro A, Froio A, et al. The Role of Imaging in the Diagnosis of Recurrence of Primary Seminal Vesicle Adenocarcinoma. World J Mens Health. 2014;32(1):61.CrossRefPubMedPubMedCentral
18.
Katafigiotis I, Sfoungaristos S, Duvdevani M, Mitsos P, Roumelioti E, Stravodimos K, et al. Primary adenocarcinoma of the seminal vesicles. A review of the literature. Arch Ital Di Urol E Androl. 2016;88(1):47–51.CrossRef
19.
Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, et al. Colon cancer, NCCN Clinical Practice Guidelines in Oncology. Jnccn J Natl Compr Cancer Netw. 2021;19(3):329–59.CrossRef
20.
Aponte-Colon DA, Xu JT, Sorcini A. Seminal vesicle mass: An unusual site for metastatic hepatocellular carcinoma after orthotopic liver transplant. Urol Case Rep. 2021;9;40:101938.
21.
Spencer KL, van der Velden JM, Wong E, Seravalli E, Sahgal A, Chow E, Verlaan JJ, Verkooijen HM, van der Linden YM. Systematic Review of the Role of Stereotactic Radiotherapy for Bone Metastases. J Natl Cancer Inst. 2019;1;111(10):1023–32.
22.
De Felice F, Piccioli A, Musio D, Tombolini V. The role of radiation therapy in bone metastases management. Oncotarget. 2017;11;8(15):25691–9.CrossRefPubMedPubMedCentral
23.
Metadata
Title
Seminal vesicle metastasis from transverse colon adenocarcinoma: a unique case report
Authors
Juliana Arenas Hoyos
Julian Serrano Giraldo
Andres Felipe Gutierrez Rojas
Publication date
23-02-2024
Publisher
Springer Vienna
Published in
memo - Magazine of European Medical Oncology
Print ISSN: 1865-5041
Electronic ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-023-00951-9
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits